News

Pharmabiz7h
Sobi’s Gamifant receives US FDA approval for first-ever treatment for adults and children with MAS in Still's disease
Stockholm, Sweden Monday, June 30, 2025, 10:00 Hrs [IST] ...
PMLiVE11h
FDA approves Sobi’s Gamifant to treat severe inflammatory arthritis complication
The drug has been authorised to treat adult and paediatric patients with haemophagocytic lymphohistiocytosis (HLH)/MAS in known or suspected Still’s disease, including systemic juvenile idiopathic ...